Advertisement

Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study)

      We sought to develop a multiple biomarker approach for prediction of incident major adverse cardiac events (MACE; composite of cardiovascular death, myocardial infarction, and stroke) in patients referred for coronary angiography. In a 649-participant training cohort, predictors of MACE within 1 year were identified using least-angle regression; over 50 clinical variables and 109 biomarkers were analyzed. Predictive models were generated using least absolute shrinkage and selection operator with logistic regression. A score derived from the final model was developed and evaluated with a 278-patient validation set during a median of 3.6 years follow-up. The scoring system consisted of N-terminal pro B-type natriuretic peptide (NT-proBNP), kidney injury molecule-1, osteopontin, and tissue inhibitor of metalloproteinase-1; no clinical variables were retained in the predictive model. In the validation cohort, each biomarker improved model discrimination or calibration for MACE; the final model had an area under the curve (AUC) of 0.79 (p <0.001), higher than AUC for clinical variables alone (0.75). In net reclassification improvement analyses, addition of other markers to NT-proBNP resulted in significant improvement (net reclassification improvement 0.45; p = 0.008). At the optimal score cutoff, we found 64% sensitivity, 76% specificity, 28% positive predictive value, and 93% negative predictive value for 1-year MACE. Time-to-first MACE was shorter in those with an elevated score (p <0.001); such risk extended to at least to 4 years. In conclusion, in a cohort of patients who underwent coronary angiography, we describe a novel multiple biomarker score for incident MACE within 1 year (NCT00842868).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lozano R.
        • Naghavi M.
        • Foreman K.
        • Lim S.
        • Shibuya K.
        • Aboyans V.
        • Abraham J.
        • Adair T.
        • Aggarwal R.
        • Ahn S.Y.
        • AlMazroa M.A.
        • Alvarado M.
        • Anderson H.R.
        • Anderson L.M.
        • Andrews K.G.
        • Atkinson C.
        • Baddour L.M.
        • Barker-Collo S.
        • Bartels D.H.
        • Bell M.L.
        • Benjamin E.J.
        • Bennett D.
        • Bhalla K.
        • Bikbov B.
        • Abdulhak A.B.
        • Birbeck G.
        • Blyth F.
        • Bolliger I.
        • Boufous S.
        • Bucello C.
        • Burch M.
        • Burney P.
        • Carapetis J.
        • Chen H.
        • Chou D.
        • Chugh S.S.
        • Coffeng L.E.
        • Colan S.D.
        • Colquhoun S.
        • Colson K.E.
        • Condon J.
        • Connor M.D.
        • Cooper L.T.
        • Corriere M.
        • Cortinovis M.
        • de Vaccaro K.C.
        • Couser W.
        • Cowie B.C.
        • Criqui M.H.
        • Cross M.
        • Dabhadkar K.C.
        • Dahodwala N.
        • De Leo D.
        • Degenhardt L.
        • Delossantos A.
        • Denenberg J.
        • Des Jarlais D.C.
        • Dharmaratne S.D.
        • Dorsey E.R.
        • Driscoll T.
        • Duber H.
        • Ebel B.
        • Erwin P.J.
        • Espindola P.
        • Ezzati M.
        • Feigin V.
        • Flaxman A.D.
        • Forouzanfar M.H.
        • Fowkes F.G.R.
        • Franklin R.
        • Fransen M.
        • Freeman M.K.
        • Gabriel S.E.
        • Gakidou E.
        • Gaspari F.
        • Gillum R.F.
        • Gonzalez-Medina D.
        • Halasa Y.A.
        • Haring D.
        • Harrison J.E.
        • Havmoeller R.
        • Hay R.J.
        • Hoen B.
        • Hotez P.J.
        • Hoy D.
        • Jacobsen K.H.
        • James S.L.
        • Jasrasaria R.
        • Jayaraman S.
        • Johns N.
        • Karthikeyan G.
        • Kassebaum N.
        • Keren A.
        • Khoo J.-P.
        • Knowlton L.M.
        • Kobusingye O.
        • Koranteng A.
        • Krishnamurthi R.
        • Lipnick M.
        • Lipshultz S.E.
        • Ohno S.L.
        • Mabweijano J.
        • MacIntyre M.F.
        • Mallinger L.
        • March L.
        • Marks G.B.
        • Marks R.
        • Matsumori A.
        • Matzopoulos R.
        • Mayosi B.M.
        • McAnulty J.H.
        • McDermott M.M.
        • McGrath J.
        • Memish Z.A.
        • Mensah G.A.
        • Merriman T.R.
        • Michaud C.
        • Miller M.
        • Miller T.R.
        • Mock C.
        • Mocumbi A.O.
        • Mokdad A.A.
        • Moran A.
        • Mulholland K.
        • Nair M.N.
        • Naldi L.
        • Narayan K.M.V.
        • Nasseri K.
        • Norman P.
        • O'Donnell M.
        • Omer S.B.
        • Ortblad K.
        • Osborne R.
        • Ozgediz D.
        • Pahari B.
        • Pandian J.D.
        • Rivero A.P.
        • Padilla R.P.
        • Perez-Ruiz F.
        • Perico N.
        • Phillips D.
        • Pierce K.
        • Pope III, C.A.
        • Porrini E.
        • Pourmalek F.
        • Raju M.
        • Ranganathan D.
        • Rehm J.T.
        • Rein D.B.
        • Remuzzi G.
        • Rivara F.P.
        • Roberts T.
        • De León F.R.
        • Rosenfeld L.C.
        • Rushton L.
        • Sacco R.L.
        • Salomon J.A.
        • Sampson U.
        • Sanman E.
        • Schwebel D.C.
        • Segui-Gomez M.
        • Shepard D.S.
        • Singh D.
        • Singleton J.
        • Sliwa K.
        • Smith E.
        • Steer A.
        • Taylor J.A.
        • Thomas B.
        • Tleyjeh I.M.
        • Towbin J.A.
        • Truelsen T.
        • Undurraga E.A.
        • Venketasubramanian N.
        • Vijayakumar L.
        • Vos T.
        • Wagner G.R.
        • Wang M.
        • Wang W.
        • Watt K.
        • Weinstock M.A.
        • Weintraub R.
        • Wilkinson J.D.
        • Woolf A.D.
        • Wulf S.
        • Yeh P.-H.
        • Yip P.
        • Zabetian A.
        • Zheng Z.-J.
        • Lopez A.D.
        • Murray C.J.L.
        Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010.
        Lancet. 2012; 380: 2095-2128
      1. WHO, Global Status Report on Noncommunicable Diseases. World Health Organization, Geneva2010: 1-176
        • Thom T.
        • Haase N.
        • Rosamond W.
        • Howard V.J.
        • Rumsfeld J.
        • Manolio T.
        • Zheng Z.-J.
        • Flegal K.
        • O'Donnell C.
        • Kittner S.
        • Lloyd-Jones D.
        • Goff D.C.
        • Hong Y.
        • Adams R.
        • Friday G.
        • Furie K.
        • Gorelick P.
        • Kissela B.
        • Marler J.
        • Meigs J.
        • Roger V.
        • Sidney S.
        • Sorlie P.
        • Steinberger J.
        • Wasserthiel-Smoller S.
        • Wilson M.
        • Wolf P.
        Heart disease and stroke statistics—2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
        Circulation. 2006; 113: e85-e151
        • Morrow D.A.
        • Antman E.M.
        • Charlesworth A.
        • Cairns R.
        • Murphy S.A.
        • de Lemos J.A.
        • Giugliano R.P.
        • McCabe C.H.
        • Braunwald E.
        TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy.
        Circulation. 2000; 102: 2031-2037
        • Boersma E.
        • Pieper K.S.
        • Steyerberg E.W.
        • Wilcox R.G.
        • Chang W.-C.
        • Lee K.L.
        • Akkerhuis K.M.
        • Harrington R.A.
        • Deckers J.W.
        • Armstrong P.W.
        • Lincoff A.M.
        • Califf R.M.
        • Topol E.J.
        • Simoons M.L.
        Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an International Trial of 9461 patients. The PURSUIT Investigators.
        Circulation. 2000; 101: 2557-2567
        • Sakamoto J.T.
        • Liu N.
        • Koh Z.X.
        • Fung N.X.
        • Heldeweg M.L.
        • Ng J.C.
        • Ong M.E.
        Comparing HEART, TIMI, and GRACE scores for prediction of 30-day major adverse cardiac events in high acuity chest pain patients in the emergency department.
        Int J Cardiol. 2016; 221: 759-764
        • Ridker P.M.
        • Rifai N.
        • Rose L.
        • Buring J.E.
        • Cook N.R.
        Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
        N Engl J Med. 2002; 347: 1557-1565
        • Wang T.J.
        • Larson M.G.
        • Levy D.
        • Benjamin E.J.
        • Leip E.P.
        • Omland T.
        • Wolf P.A.
        • Vasan R.S.
        Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
        N Engl J Med. 2004; 350: 655-663
        • Cesari M.
        • Penninx B.W.J.H.
        • Newman A.B.
        • Kritchevsky S.B.
        • Nicklas B.J.
        • Sutton-Tyrrell K.
        • Rubin S.M.
        • Ding J.
        • Simonsick E.M.
        • Harris T.B.
        • Pahor M.
        Inflammatory markers and onset of cardiovascular events. Results from the Health ABC Study.
        Circulation. 2003; 108: 2317-2322
        • Blankenberg S.
        • McQueen M.J.
        • Smieja M.
        • Pogue J.
        • Balion C.
        • Lonn E.
        • Rupprecht H.J.
        • Bickel C.
        • Tiret L.
        • Cambien F.
        • Gerstein H.
        • Münzel T.
        • Yusuf S.
        Comparative impact of multiple biomarkers and n-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study.
        Circulation. 2006; 114: 201-208
        • Gaggin H.K.
        • Bhardwaj A.
        • Belcher A.M.
        • Motiwala S.R.
        • Gandhi P.U.
        • Simon M.L.
        • Kelly N.P.
        • Anderson A.M.
        • Garasic J.M.
        • Danik S.B.
        • Schwamm L.H.
        • Gerszten R.E.
        • van Kimmenade R.R.J.
        • Januzzi Jr., J.L.
        Design, methods, baseline characteristics and interim results of the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study.
        IJC Metab Endocr. 2014; 5: 11-18
        • Gaggin H.K.
        • Liu Y.
        • Lyass A.
        • van Kimmenade R.R.
        • Motiwala S.R.
        • Kelly N.
        • Mallick A.
        • Gandhi P.U.
        • Ibrahim N.E.
        • Simon M.
        • Bhardwaj A.
        • Belcher A.
        • Harisiades J.E.
        • Massaro J.M.
        • D'Agostino Sr., R.B.
        • Januzzi J.L.
        Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography.
        Circulation. 2017; 135: 116-127
        • Efron B.
        • Hastie T.
        • Johnstone I.
        • Tibshirani R.
        Least angle regression.
        Ann Statist. 2004; 32: 407-499
        • Tibshirani R.
        Regression shrinkage and selection via the LASSO: a retrospective.
        J R Stat Soc Ser B Stat Methodol. 2011; 73: 273-282
        • Kinnunen P.
        • Vuolteenaho O.
        • Ruskoaho H.
        Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.
        Endocrinology. 1993; 132: 1961-1970
        • Sabatine M.S.
        • Morrow D.A.
        • de Lemos J.A.
        • Omland T.
        • Desai M.Y.
        • Tanasijevic M.
        • Hall C.
        • McCabe C.H.
        • Braunwald E.
        Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia.
        J Am Coll Cardiol. 2004; 44: 1988-1995
        • Medic B.
        • Rovcanin B.
        • Basta Jovanovic G.
        • Radojevic-Skodric S.
        • Prostran M.
        Kidney injury molecule-1 and cardiovascular diseases: from basic science to clinical practice.
        Biomed Res Int. 2015; 2015: 854070
        • Minoretti P.
        • Falcone C.
        • Calcagnino M.
        • Emanuele E.
        • Buzzi M.P.
        • Coen E.
        • Geroldi D.
        Prognostic significance of plasma osteopontin levels in patients with chronic stable angina.
        Eur Heart J. 2006; 27: 802-807
        • Akahane T.
        • Akahane M.
        • Shah A.
        • Thorgeirsson U.P.
        TIMP-1 stimulates proliferation of human aortic smooth muscle cells and ras effector pathways.
        Biochem Biophys Res Commun. 2004; 324: 440-445
        • Lafleur M.A.
        • Handsley M.M.
        • Edwards D.R.
        Metalloproteinases and their inhibitors in angiogenesis.
        Expert Rev Mol Med. 2003; 5: 1-39
        • Guedez L.
        • Mansoor A.
        • Birkedal-Hansen B.
        • Lim M.S.
        • Fukushima P.
        • Venzon D.
        • Stetler-Stevenson W.G.
        • Stetler-Stevenson M.
        Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in b-cell differentiation and lymphomagenesis.
        Blood. 2001; 97: 1796-1802
        • Apparailly F.
        • Noel D.
        • Millet V.
        • Baker A.H.
        • Lisignoli G.
        • Jacquet C.
        • Kaiser M.J.
        • Sany J.
        • Jorgensen C.
        Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis.
        Arthritis Rheum. 2001; 44: 1444-1454
        • Cavusoglu E.
        • Ruwende C.
        • Chopra V.
        • Yanamadala S.
        • Eng C.
        • Clark L.T.
        • Pinsky D.J.
        • Marmur J.D.
        Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction.
        Am Heart J. 2006; 151: 1101.e1101-1101.e1108
        • Arroyo L.H.
        • Lee R.T.
        Mechanisms of plaque rupture. Mechanical and biologic interactions.
        Cardiovasc Res. 1999; 41: 369-375
        • Eapen D.J.
        • Manocha P.
        • Patel R.S.
        • Hammadah M.
        • Veledar E.
        • Wassel C.
        • Nanjundappa R.A.
        • Sikora S.
        • Malayter D.
        • Wilson P.W.F.
        • Sperling L.
        • Quyyumi A.A.
        • Epstein S.E.
        Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes.
        J Am Coll Cardiol. 2013; 62: 329-337